Abstract
Nanotechnology has been the last frontier in the diagnoses and treatment of many diseases, especially in oncology. The use of nanoparticles of radiopharmaceuticals may represent the future of Nuclear Medicine. In this study we developed, characterized and tested polymeric nanoparticles of FMISO (fluoromisonidazole) in a dynamic study of biodistribution. The results of the development as characterization showed that nanoparticles were well obtained with a size range of 300- 500nm and a spherical shape.
Keywords: Radiopharmaceuticals, Oncology, Nuclear Medicine, Hypoxia, Predictive.
Current Radiopharmaceuticals
Title:Polymeric Nanoparticles of FMISO: Are Nano-Radiopharmaceuticals Better Than Conventional Ones?
Volume: 5 Issue: 4
Author(s): Marta de Souza Albernaz, Beatriz Ferreira de Carvalho Patricio, Gilberto Weissmuller, Franceline Reynaud, Tom CH Adamsen and Ralph Santos-Oliveira
Affiliation:
Keywords: Radiopharmaceuticals, Oncology, Nuclear Medicine, Hypoxia, Predictive.
Abstract: Nanotechnology has been the last frontier in the diagnoses and treatment of many diseases, especially in oncology. The use of nanoparticles of radiopharmaceuticals may represent the future of Nuclear Medicine. In this study we developed, characterized and tested polymeric nanoparticles of FMISO (fluoromisonidazole) in a dynamic study of biodistribution. The results of the development as characterization showed that nanoparticles were well obtained with a size range of 300- 500nm and a spherical shape.
Export Options
About this article
Cite this article as:
de Souza Albernaz Marta, Ferreira de Carvalho Patricio Beatriz, Weissmuller Gilberto, Reynaud Franceline, CH Adamsen Tom and Santos-Oliveira Ralph, Polymeric Nanoparticles of FMISO: Are Nano-Radiopharmaceuticals Better Than Conventional Ones?, Current Radiopharmaceuticals 2012; 5 (4) . https://dx.doi.org/10.2174/1874471011205040336
DOI https://dx.doi.org/10.2174/1874471011205040336 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Challenges in Lung Cancer Approaches: from the Clinical Issues to the Novel Therapies
Recent Advances in DNA & Gene Sequences (Discontinued) Design of Zein Conjugation and Surface Modification for Targeting Drug Delivery
Current Drug Targets Topotecan in Second-Line Treatment of Small-Cell Lung Cancer – How it Works in Our Daily Clinical Practice?
Current Drug Safety Editorial [ Hot Topic: Highlights on Important Signaling Pathways as Drug Targets in Hematological Malignancies (Guest Editors: H. Serve and H.C. Hasselbalch) ]
Current Drug Targets Emerging Therapies in the Treatment of Locally Advanced Squamous Cell Cancers of Head and Neck
Recent Patents on Anti-Cancer Drug Discovery Recent Developments in Protein and Cell-Targeted Aptamer Selection and Applications
Current Medicinal Chemistry Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in Cancer
Current Drug Targets VEGF Inhibitors in Cancer Therapy
Current Pharmaceutical Design Lung Cancer Mutations and Use of Targeted Agents in Hispanics
Reviews on Recent Clinical Trials Engineered Nanoparticles for Improved Vasoactive Intestinal Peptide (VIP) Biomedical Applications
Recent Patents on Nanomedicine Lights and Shadows on Monoamine Oxidase Inhibition in Neuroprotective Pharmacological Therapies
Current Topics in Medicinal Chemistry The Role of Saffron in Attenuating Age-related Oxidative Damage in Rat Hippocampus
Recent Patents on Food, Nutrition & Agriculture Modulation of Energy Intake and Expenditure Due to Habitual Physical Exercise
Current Pharmaceutical Design Insights on the Isolation, Biological Activity and Synthetic Protocols of Enyne Derivatives
Current Topics in Medicinal Chemistry Liposomes as Nanovaccine Delivery Systems
Current Topics in Medicinal Chemistry Chloroquine Assisted Delivery of microRNA Mimic Let-7b to NSCLC Cell Line by PAMAM (G5) - HA Nano-Carrier
Current Drug Delivery Protein Kinases as Drug Targets in Cancer
Current Cancer Drug Targets Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease
Current Chemical Biology Sulfonamides as Potential Bioactive Scaffolds
Current Organic Chemistry Network of WNT and Other Regulatory Signaling Cascades in Pluripotent Stem Cells and Cancer Stem Cells
Current Pharmaceutical Biotechnology